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Depriving cells of iron likely stresses them and can result in cell death. To examine the potential relationship between this form of stress
and cell death, Jurkat T-lymphocytes were made iron-deficient by exposing them to the iron chelator, deferoxamine (DFO). Such treatment
produced evidence of apoptosis, including cell shrinkage, membrane blebbing, chromatin condensation and fragmentation, and also
formation of apoptotic bodies. Additionally, proteolytic cleavage of poly(ADP-ribose)polymerase was detected, suggesting involvement of
caspases in initiating apoptosis. Indeed, a selective caspase-3 inhibitor prevented the effects of DFO. During the early induction period of
apoptosis, GRP78 and HSP70 mRNA expression was not affected. In contrast, there was mainly increased mRNA expression of Growth
Arrest and DNA Damage-inducible gene 153 (GADD153), which seemed to be at the level of transcription rather than mRNA stability.
Furthermore, fortifying cells with antioxidants did not prevent the increased GADD153 mRNA expression, and no evidence of single-strand
breaks in DNA was found, suggesting that neither reactive oxygen species nor DNA damage was involved in triggering GADD153 gene
activation. DFO also caused GADD153 protein to be expressed. Because GADD153 is recognized as a pro-apoptotic gene, these findings
generate the notion that GADD153 might help mediate apoptosis in iron-deficient cells.
D 2004 Elsevier B.V. All rights reserved.Keywords: Apoptosis; Caspase-3; GADD153; Iron; Iron deficiency1. Introduction
Proper levels of iron are needed by cells to help ensure
their viability and proliferative capacity. Iron was initially
recognized as an essential trace element for all dividing cells
upon finding that DNA synthesis was impaired in human
lymphocytes rendered iron-deficient with the iron chelator,
deferoxamine (DFO) [1]. This effect of cellular iron defi-
ciency can be attributed to decreased activity of ribonucle-
otide reductase [2], an iron-dependent enzyme that converts
ribonucleotides into deoxyribonucleotides as a prerequisite
step for DNA synthesis. As a result, there is growth arrest of
iron-deficient cells in the S-phase of the cell cycle [3].
Transcriptional activation of certain genes initiates down-
stream events leading to the cell cycle arrest. For example, it
is known that DFO-induced cellular iron deficiency
increases the levels of transcription factor p53, which in turn0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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1/p21 gene [4]. Subsequently, the p21 gene product inhibits
cyclin-dependent kinases that otherwise would promote cell
cycle progression.
When impairment of DNA synthesis and cell division
becomes critical, iron-deficient cells start to die with evi-
dence of apoptosis being apparent [5,6], but the precise cell
death pathway leading to apoptosis has not been completely
elucidated. However, there is the suggestion from widely
accepted models of apoptosis [7] that iron deficiency-in-
duced apoptosis is initiated by caspases. Activation of
caspases is pivotal for later occurrence of the DNA frag-
mentation and morphological changes characteristic of apo-
ptosis [8]. Hence, because DNA fragmentation [5,6] and
morphological changes [6] occur in iron-deficient cells, the
possible involvement of caspases, specifically caspase-3, in
initiating apoptosis in iron-deficient Jurkat T-lymphocytes
was initially investigated to help clarify the chain of events
leading to cell death.
It is generally believed that changes in gene expression
are important in promoting cell death by apoptosis in iron-
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shown that DFO-induced iron deficiency in human breast
cancer cells caused apoptosis, which was accompanied by
changes in the expression of the pro-apoptotic Bax gene
and the anti-apoptotic Bcl-2 gene [9]. However, it is
conceivable that other genes could also be involved in
mediating apoptosis in iron-deficient cells. Because de-
priving cells of iron likely creates a stressful cellular
environment, another aim of this present study was to
determine if the expression of certain stress-response
genes is increased in iron-deficient Jurkat T-lymphocytes,
in establishing a possible association between the stress-
response gene expression and occurrence of cell death.2. Materials and methods
2.1. Materials
Jurkat T-lymphocytes, a human lymphoblastoid T-cell
line, were purchased from ATCC (Rockville, MD). Defer-
oxamine mesylate (DFO), 2,2-dipyridyl (DPD), and dieth-
ylenetriaminepentaacetic acid (DTPA) and all other
common reagents were purchased from Sigma Chemical
Co. (St. Louis, MO).Fig. 1. Morphological appearance of Jurkat T-lymphocytes exposed to DFO. Cells
for 14 h (DFO-treated cells) and then examined by phase-contrast light microscop
control cells and DFO-treated cells were stained with DAPI and then examined by
experiments.2.2. Cell culture and treatment of cells
Jurkat T-lymphocytes were propagated in RPMI-1640
media (Sigma) supplemented with 100 ml/l fetal bovine
serum (BioWhittaker Inc., Walkersville, MD), 2 mmol/
l glutamine, 0.54 Amol/l fungizone, 100,000 units/l penicil-
lin, and 100 mg/l streptomycin (last four items from Atlanta
Biologicals, Atlanta, GA). To make the cells iron-deficient
[10], they were incubated with 100 AM DFO for periods up
to 24 h to chelate intracellular iron. DPD and DTPA were
utilized similarly to confirm the effects of DFO. Other cell
samples were pretreated for 3 h with 600 AM Ac-DEVD-
CHO (Calbiochem, San Diego, CA) before exposing them to
DFO. In some experiments, control cells and cells exposed to
DFO were subsequently incubated with actinomycin D (1–5
Ag/ml). In other experiments, cells were pretreated with
either a-tocopherol (100 AM) for 24 h, or N-acetylcysteine
(20 mM) for 2 h, before exposing the cells to DFO.
2.3. Examination of cells for morphological evidence of
apoptosis
Using an Olympus IX-70 inverted microscope/SPOT
digital camera system, 200 randomly selected cells were
scored visually for the presence of cell shrinkage, plasma
ysica Acta 1691 (2004) 41–50(5 105) were incubated either without (control cells) or with 100 AM DFO
y (A). To assess chromatin condensation and fragmentation in the cells, the
fluorescence microscopy (B). The results are representative of three different
Fig. 2. Detection of proteolytic cleavage of PARP in DFO-treated Jurkat T-
lymphocytes (A) and prevention of DFO-induced apoptosis by the selective
caspase-3 inhibitor, Ac-DEVD-CHO (B). In (A), cells (2 106) were
incubated with 100 AM DFO for different times as noted above. After SDS-
PAGE/Western-blotting, PARP appeared as a single band with an apparent
molecular mass of 113 kDa. The main cleavage product of PARP was
detected as a secondary band of 89 kDa. The results are representative of
three different experiments. In (B), cells (5 105) were pre-incubated
without ( ) or with (+) 600 AM Ac-DEVD-CHO for 3 h. These cells were
then incubated without ( ) or with (+) 100 AM DFO for 14 h. They were
scored for the presence of morphological features characteristic of apoptosis
(% apoptotic cells). Values are the meansF S.E., n= 3. bP < 0.01 compared
to other treatments.
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apoptotic bodies, which all are basic markers of apoptosis
[11]. Additionally, cells were fixed with 4% formaldehyde
and stained with 1 Ag/ml 4V,6-diamidino-2-phenylindole
(DAPI) to visualize the extent of chromatin condensation
and fragmentation using an Olympus BX-60 fluorescence
microscope equipped with a UV filter.
2.4. Detection of proteolytic cleavage of poly-(ADP-ribose)-
polymerase (PARP)
At different time points, cells were harvested and washed
with ice-cold phosphate-buffered saline (PBS) and then
resuspended in PBS containing phenylmethylsulfonyl fluo-
ride (0.1 mg/ml) for sonication on ice. Protein concentration
of the lysates was determined with a Bio-Rad DC protein
assay kit (Bio-Rad, Hercules, CA). Next, 30 Ag of cellular
protein was processed for SDS/PAGE using 12% Tris-
glycine pre-cast gels (Novex, San Diego, CA). The sepa-
rated proteins on the gels were blotted to nitrocellulose
membrane, which was probed with a murine anti-PARP
antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA)
and then with a horseradish peroxidase-conjugated rabbit
anti-mouse antibody. Detection of immunosignal was
achieved by enhanced chemiluminescence (ECL, Amer-
sham, Arlington, IL) using Fuji X-ray film.
2.5. Determination of GRP78, HSP70, and Growth Arrest
and DNA Damage-inducible gene 153 (GADD153) mRNA
expression
Total RNA was isolated from the cells using a Qiagen
RNeasy Mini kit. The expression levels of GRP78, HSP70,
and GADD153 mRNA were determined by multiplex rela-
tive RT-PCR analysis of total RNA using a Qiagen OneStep
RT-PCR kit and gene-specific primers. The PCR primer base
sequences for GRP78 and HSP70 were from the NCBI
UniSTS data-base of NIH. For GRP78 (UniSTS:48897)—
forward primer: GCCTAAGCGGCTGTTTACTG, reverse
primer: AACTTCCTACACCAGATGCACA, PCR product
size: 174–175 (bp). For HSP70 (UniSTS:70149)—forward
primer: TGACTGTCAGGGCTATGCTAT, reverse primer:
CAATGTTAAAGTGCCACACAAG, PCR product size:
203 (bp). The GADD153 PCR primer sequences (sense:
5V-GCACCTCCCAGAGCCCTCACTCTCC-3Vand anti-
sense: 5V-GTCTACTCCAAGCCTTCCCCCTGCG-3V)
were exactly the same as that used originally by Mertani et
al. [12] and gave a PCR product size of 422 bp. Either the h-
actin or 18S rRNA QuantumRNA primer/competimer sets
(Ambion, Inc., Austin, TX) were used to generate internal
standards with cDNA product sizes of 294 and 495 bp,
respectively. The RT-PCR conditions for GRP78 and HSP70
were 30 min at 48 jC followed by 15 min at 95 jC (RT), then
0.5 min at 94 jC, 0.5 min at 48 jC, and 1 min at 72 jC for 32
cycles (GRP-78) or 34 cycles (HSP-70) (PCR). The RT-PCR
conditions for GADD153 were 30 min at 50 jC followed by15 min at 95 jC (RT), then 0.5 min at 95 jC, 0.5 min at 60
jC, and 1 min at 72 jC for 25 cycles (PCR). The resulting
cDNA products were separated by 2% agarose gel electro-
phoresis with ethidium bromide staining.
2.6. Determination of GADD153 protein expression
Cells were harvested and washed by centrifugation
(500 g for 5 min) in Hanks Balanced Salt Solution
(HBSS). The cell pellets were frozen at  80C. To prepare
whole cell lysates, the frozen cell pellets were thoroughly
resuspended in lysis buffer (50 mM Tris–HCl, 150 mM
NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1
mM sodium orthovanadate, 1 mM sodium fluoride, Com-
plete Protease Inhibitor Cocktail from Roche-Boehringer
Mannheim, pH 7.4) and left on ice for 30 min. Next, the
samples were centrifuged at 16,000 g for 20 min at 4C.
The protein concentrations of the whole cell lysates (super-
natant) were determined with a BCA protein assay kit
(Pierce Inc.).
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were loaded into the wells of Novex pre-cast NuPAGE
mini-gels (4–12% Bis-Tris). The gel-separated proteins
were transferred to nitrocellulose membrane (Pierce), which
was then incubated for 1 h at 25 C in blocking buffer
consisting of 5% skim milk powder in TBST (20 mM Tris–
HCl, 150 mM sodium chloride, 0.05% Tween 20, pH 7.4).
Next, the nitrocellulose membrane was incubated overnight
at 4C with GADD153 rabbit polyclonal R-20 antibody
(Santa Cruz) in blocking buffer (1:5000). After washing
in TBST, the membrane was then incubated 2 h at 25C with
goat anti-rabbit IgG/HRP conjugate (Santa Cruz) in block-
ing buffer (1:100,000). Finally, after washing again in
TBST, the membrane was placed in a plastic pouch for
incubation with chemiluminescent reagent (Pierce Super-
Signal WestFemto Maximum Sensitivity Substrate) for 5
min for subsequent analysis on a Kodak digital sciencek
image station 440 CF. After densitometry, the nitrocellulose
membrane was kept in the plastic pouch and in the dark at
25 jC overnight, before reprobing for h-actin as a control
for sample loading onto the gels. The membrane was
washed with TBST, and incubated 2 h at 25 jC with mouseFig. 3. Expression of GRP78, HSP70, and GADD153 mRNA in Jurkat T-lym
lymphocytes were incubated with 100 AM deferoxamine (DFO) for multiple time
multiplex relative RT-PCR analysis of mRNA using gene specific primers for the
cells were exposed to 100 AM DFO for either 15 (left gel) or 16 h (right gel). Tota
control genes, h-Actin and 18S rRNA.monoclonal anti-h-actin antibody (Sigma) in blocking buff-
er (1:50,000). After incubation for 1 h at 25 jC with HRP-
conjugated goat polyclonal anti-mouse IgG (Santa Cruz) in
blocking buffer (1:100,000), the membrane was washed in
TBST and processed for analysis as before.
2.7. Assessment of DNA damage
Single-strand breaks in DNA were assessed in the cells
by the comet assay, as previously described [13]. Basically,
cells resuspended in agarose gel were cast onto glass slides.
Following treatment of the supported cells with alkaline
detergent to remove membranes, the resulting nucleoids
were subjected to electrophoresis. Nucleoid DNA was
stained with ethidium bromide to permit visualization by
fluorescence microscopy.
2.8. Statistical analysis of data
Where applicable, data were analyzed for statistical
differences by analysis of variance (ANOVA) using a stan-
dard SAS program (version 6.12).phocytes after induction of iron deficiency with DFO. In (A), Jurkat T-
points up to 18 h. Total RNA was isolated from the harvested samples for
target genes, GRP78 and HSP70, and internal control gene, h-actin. In (B),
l RNAwas isolated for the determination of GADD153 and the two internal
Fig. 4. Expression of GADD153 mRNA and protein in Jurkat T-
lymphocytes after induction of iron deficiency. Cells were incubated with
100 AM DFO, DPD, or DTPA for 16 h. Other cells were co-incubated with
100 AM DFO and 50 AM ferrous sulfate for 16 h. Then, GADD153 and h-
actin mRNA expression levels were determined by multiplex relative RT-
PCR analysis (A). GADD153 and h-actin protein expression levels were
determined by Western-immunoblotting analysis (B).
Y.-J. Pan et al. / Biochimica et Biophysica Acta 1691 (2004) 41–50 453. Results
3.1. Morphological changes in iron-deficient cells
Upon examination by phase-contrast light microscopy
(Fig. 1A), control or iron-sufficient cells were whole with
smooth surface membranes. From this single view alone,
none of the cells had irregular morphology. Nevertheless,
after total scoring, about 5% of control cells were judged to
have a morphological appearance characteristic of apoptosis,
which is a percentage typically expected in culturing Jurkat
T-lymphocytes. In contrast, many of the DFO-treated cells
looked irregular. That is, after total scoring, about 40% of the
cells were shrunken, had blebbing surface membranes, and/
or were in the process of breaking up into small apoptotic
bodies. After DAPI-staining of the cells for examination by
fluorescence microscopy (Fig. 1B), it can be seen that
chromatin was mainly intact in nuclei of control cells, in
marked contrast to the chromatin in many of the DFO-treated
cells. More specifically, after total scoring, 2% of control
cells and 48% of DFO-treated cells had chromatin conden-
sation and/or fragmentation. Thus, these particular findings
provide further morphological evidence of apoptosis in iron-
deficient Jurkat T-lymphocytes.
3.2. Degradation of PARP in iron-deficient cells
In popular models of apoptosis [7], caspases are activated
to function in the enzymatic degradation of numerous
intracellular proteins having vital metabolic roles. PARP,
which is involved in DNA repair, is a primary example of a
protein degraded or cleaved by activated caspases during
apoptosis [14]. Accordingly, to determine if PARP cleavage
occurred in DFO-treated Jurkat T-lymphocytes, Western-
blotting analysis was performed (Fig. 2A). PARP was
detected as a band with an apparent molecular mass of 113
kDa. Following exposure of cells to DFO, a PARP cleavage
product having an apparent molecular mass of 89 kDa was
also detected. This product was not detectable until 10 h after
exposing the cells to DFO, with peak appearance between 14
and 18 h. Therefore, the occurrence of PARP cleavage in the
iron-deficient Jurkat T-lymphocytes strongly suggested that
caspases could have been activated because caspases are
known to be responsible for PARP cleavage [15,16].
3.3. Requirement for caspase-3 in mediating cell death
induced by DFO
Morphological features of apoptosis are known to be-
come apparent as a result of caspase-3 action [8]. Further-
more, caspase-3 is known to recognize PARP as a substrate
and catalyze its cleavage [14]. Hence, to determine the
requirement for caspase-3 in mediating cell death in iron-
deficient Jurkat T-lymphocytes, we utilized the selective
caspase-3 inhibitor, Ac-DEVD-CHO [17]. As shown in Fig.
2B, less than 5% of the control cells (i.e., cells not treatedwith DFO and/or Ac-DEVD-CHO) showed morphological
evidence of apoptosis. However, more than 35% of the cells
exposed to DFO had apoptotic morphology, but pretreating
cells with Ac-DEVD-CHO prevented this effect by DFO.
The eventual longer-term fate of these caspase-3 inhibitor-
treated, iron-deficient cells was not determined. However, it
is likely that they would not survive without a source of
iron. Thus, it is conceivable that either necrosis occurs or a
caspase-3-independent cell death pathway is initiated in
such cells.
3.4. Effect of cellular iron deficiency on GRP78, HSP70,
and GADD153 mRNA expression
GRP78 and HSP70 are two stress genes that are fre-
quently activated in cells as an early response to being
exposed to a stressful environment. Because making cells
iron-deficient likely stresses them, GRP78 and HSP70
mRNA expression was determined in iron-deficient Jurkat
T-lymphocytes (Fig. 3A). As can be seen, cellular iron
deficiency induced by DFO did not change mRNA expres-
sion of either GRP78 (top gel) or HSP70 (bottom gel) when
evaluated for periods up to 18 h after initially treating the
cells with DFO. In contrast, there was increased expression
of GADD153 mRNA, which was detectable by 10 h (data
not shown) but with peak expression occurring at 15–16
h as shown by the representative results from two different
experiments (Fig. 3B).
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GADD153 mRNA expression was due to iron deprivation,
two other compounds generally recognized as iron chelators
were tested. Either 2,2-dipyridyl (DPD) or diethylenetria-
minepentaacetic acid (DTPA) increased GADD153 mRNA
expression as well in Jurkat T-lymphocytes (Fig. 4A). To
determine whether the changes in GADD153 mRNA levels
reflected changes in GADD153 protein levels, Western-
immunoblotting analysis was performed. As can be seen
(Fig. 4B), DFO, DPD, and DTPA each induced GADD153
protein expression. In the case of DFO, it was further found
that co-treating Jurkat T-lymphocytes with 100 AM DFO
and 50 AM ferrous sulfate prevented up-regulation of
GADD153 mRNA and protein expression (Fig. 4A and
B), suggesting that the effect of DFO on GADD153 mRNA
expression was due to chelation of iron and not other metal
ions.Fig. 5. Influence of DFO on GADD153 mRNA expression at the transcriptional a
were incubated with 100 AM DFO for 8 h. Then, 5 Ag/ml actinomycin D (ACT)
multiplex relative RT-PCR analysis for GADD153 and h-actin mRNA expression
ml actinomycin D (ACT) was added to the cultures, and the incubation continued
for GADD153 and h-actin mRNA expression levels. In (C), the data from B w
GADD153 mRNA rate of degradation in control and DFO-treated cells.3.5. Evidence that the increased GADD153 mRNA
expression caused by DFO is at the level of transcription
To come up with a fundamental explanation for the
increased GADD153 mRNA expression in iron-deficient
Jurkat T-lymphocytes, a standard experiment utilizing acti-
nomycin D (ACT) was performed to inhibit or block
transcription (Fig. 5A). Cells in complete culture media were
incubated first with DFO for 8 h. Then, ACTwas added, and
the incubation continued for 4 h. As can be seen by the data,
exposing cells to only DFO increased GADD153 mRNA
expression (lane 3) when compared to control cells (lane 2).
This effect by DFO was prevented when cells were treated
with ACT after being exposed to DFO (lane 4). In other
experiments, GADD153 mRNA stability was not different
between control cells and cells exposed to DFO, as can be
seen in comparing GADD153 mRNA expression levels over
ysica Acta 1691 (2004) 41–50nd posttranscriptional levels as evaluated with actinomycin D. In (A), cells
was added and the incubation continued for another 4 h before subsequent
levels. In (B), cells were incubated with 100 AM DFO for 14 h. Then, 1 Ag/
for periods up to 6 h before subsequent multiplex relative RT-PCR analysis
ere analyzed by densitometry to generate the figure shown that compares
Fig. 6. Effect of antioxidants on DFO-induced up-regulation of GADD153 mRNA expression. In (A), cells were pretreated with either 100 AM a-tocopherol
dissolved in absolute ethanol (TH/EtOH) or the solvent alone (EtOH) for 24 h. In (B), cells were pretreated with 20 mM N-acetylcysteine (NAC) for 2 h. After
the cells were exposed to DFO for 15–16 h, multiplex relative RT-PCR analysis for GADD153 and h-actin mRNA was performed.
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following the exposure of cells to DFO for 14 h (Fig. 5B).
Moreover, after densitometric analysis of the Fig. 5B data
and subsequent plotting, no notable difference in the rate of
GADD153 mRNA decay can be seen when comparing the
relative slopes of the plots for control versus DFO-treated
cells (Fig. 5C).Fig. 7. Assessment of DNA damage in DFO-treated Jurkat-T lymphocytes. Cells
left). The effect of DFO in potentially inhibiting H2O2-induced DNA damage wa
before exposing to H2O2. Single-strand breaks in DNA were assessed by the com3.6. Evaluation of oxidative stress in contributing to up-
regulation of GADD153 mRNA expression
Because GADD153 is often activated as a result of
oxidative stress and DNA damage, the effect of antiox-
idants on GADD153 mRNA levels was determined. Pre-
treatment of Jurkat T-lymphocytes with either a-tocopherolwere exposed to DFO (upper right) or to H2O2 as a positive control (lower
s also examined (lower right). In this case, cells were pre-exposed to DFO
et assay.
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DFO-induced up-regulation of GADD153 mRNA expres-
sion, suggesting that reactive oxygen species were not
involved in GADD153 mRNA up-regulation. Furthermore,
as assessed by the comet assay, single-strand breaks in
DNA were not detected in DFO-treated Jurkat T-lympho-
cytes (Fig. 7), suggesting that oxidative DNA damage was
not promoted by cellular iron deficiency, and hence, could
not have led to up-regulation of GADD153 mRNA ex-
pression. As the rest of the data show, DFO actually
inhibited H2O2-induced DNA damage to a large extent,
likely because DFO chelated intracellular iron, which
otherwise can react with H2O2 to form hydroxyl radical
that ultimately damages cellular DNA.4. Discussion
In the current study, DFO was the primary iron chelator
utilized to make Jurkat T-lymphocytes iron-deficient. Cel-
lular uptake of DFO occurs by endocytosis [18]. Subse-
quently, the DFO compartmentalizes largely in lysosomes,
which contain a sizable pool of redox-active iron originating
apparently from lysosomal proteolysis of iron-containing
proteins [19]. Hence, this free iron in lysosomes, which may
help meet the overall needs of the cell, is chelated by DFO.
The unavailability or deficiency of iron induced by DFO can
result in cell death. For example, HL-60 cells died when
these cells were made iron-deficient by exposing them to
DFO [5]. Such cell death was suggested to have occurred by
way of apoptosis, based on the observation of a few cellular
features characteristic of apoptosis. In support of this
previous study [5], the present study found that DFO, or
the iron deficiency caused by DFO, caused morphological
features characteristic of apoptosis to appear in Jurkat T-
lymphocytes. At least 10–12 h of exposure of the cells to
DFO was required before any cell shrinkage, membrane
blebbing, apoptotic bodies, and chromatin condensation and
fragmentation were detectable. To expand these basic obser-
vations, the present results suggest that DFO-induced iron
deficiency caused cell death in Jurkat T-lymphocytes via a
caspase-3-dependent pathway leading to apoptosis. Two
lines of evidence support this view. First, cleavage of PARP
was detected in DFO-treated cells. It is well established that
PARP can be cleaved by caspase-3 [14]. Second, the
morphological changes caused by DFO were not seen in
Jurkat T-lymphocytes that were pretreated with the caspase-
3 inhibitor, Ac-DEVD-CHO, prior to their subsequent
exposure to DFO. This finding is consistent with the results
of other investigators [8] who reported that caspase-3
activity is required for the morphological changes associated
with apoptosis.
The upstream events leading to activation of caspase-3 in
DFO-treated Jurkat T-lymphocytes remain unknown. How-
ever, based on two popular models for apoptosis [7], the
DFO-induced cell death could have been initiated via eitherof two apoptotic pathways. Basically, in the cell surface
death receptor pathway, trimerization of cell surface recep-
tors, such as FAS (CD95), leads to activation of initiator
caspases, such as caspase-8. In turn, caspase-8 activates the
effector caspase known as caspase-3, which is the main
executioner of cells [20]. Activated caspase-3 ultimately
commits the cell to death by cleaving p21 [21], thereby
removing the p21 that promotes cell cycle arrest. On the
other hand, in the mitochondria-mediated cell death path-
way, disruption of mitochondrial membrane potential and
structural integrity occurs initially. These events permit
release of cytochrome c, which, along with Apaf-1 and
(d)ATP, forms the apoptosome. This complex activates
caspase-9, which in turn activates caspase-3. Thus, no
matter which cell death pathway is followed by iron-
deficient Jurkat T-lymphocytes, caspase-3 would be pivotal
for the process of apoptosis since the cell surface death
receptor pathway and mitochondria-mediated cell death
pathway converge to result in the activation of caspase-3.
By exposing Jurkat T-lymphocytes to DFO, it is likely
that this treatment created a stressful cellular environment
because the cells were deprived of a critical micronutrient
needed for their vitality and viability. As such, it would be
expected that stress-response genes become activated in
helping the iron-deficient cells to either survive or terminate.
Although GRP78 and HSP70 mRNA expression was not
affected by the cellular iron deficiency induced by DFO, an
important member of the GADD was up-regulated. More
specifically, GADD153 mRNA expression was increased,
which could be potentially due to increased transcription or
greater mRNA stability. Depriving cells of leucine [22]
increased GADD153 mRNA expression, which was attrib-
uted to increased transcription and mRNA stability. Gluta-
mine deprivation also induced GADD153 mRNA
expression [23], but the primary mechanism was through
mRNA stabilization. The increased GADD153 mRNA in
iron-deficient Jurkat T-lymphocytes seemed to be at the
level of transcription based on two observations. First,
actinomycin D prevented the increased GADD153 mRNA
expression caused by DFO. Second, GADD153 mRNA
stability was not different in untreated versus DFO-treated
Jurkat T-lymphocytes.
GADD genes are typically activated when cells are
subjected to various forms of stress. For example, GADD
mRNA expression increased in cells upon exposure to
stress-inducing agents, such as peroxynitrite [24], UV
radiation [25], and anti-cancer drugs [26], which also are
known to induce DNA damage. Most interesting and
relevant to the current effects of cellular iron deficiency
on GADD153 mRNA expression, depriving cells of indi-
vidual nutrients such as leucine [22], glutamine [23], glu-
cose [27], and zinc [28] created a cellular environment that
led to increased GADD153 gene expression. The molecular
cascade leading to GADD153 gene activation is known to
involve mitogen-activated protein kinases (MAPK). When
p38/SAPK2 was activated by anisomycin in Jurkat T-lym-
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this effect was nullified with a selective chemical inhibitor
of p38/SAPK2 [29].
Although cellular DNA damage can result in up-regula-
tion of GADD153 gene expression, it is important to note
that up-regulation of GADD gene expression does not
necessarily occur merely as a consequence of growth arrest
or DNA damage. Indeed, regarding the latter situation,
single-strand breaks in DNA as assessed by the comet assay
were not detected in DFO-treated Jurkat T-lymphocytes.
This finding suggests that DFO did not induce oxidative
stress, at least to a sufficient extent to cause single-strand
breaks in DNA. Instead, it was found that DFO had the
capability to inhibit H2O2-induced DNA damage in Jurkat
T-lymphocytes. In inducing DNA damage, it is generally
believed that H2O2 diffuses through cellular membranes,
including the nuclear membrane. The incoming H2O2 reacts
with transition metals such as ferrous ions that are in close
proximity or loosely bound to DNA, resulting in the
formation of hydroxyl radicals that cause oxidative damage
to DNA. However, a series of recent studies [19,30,31] have
advanced the concept that H2O2 enters lysosomes and reacts
with redox-active iron originating from lysosomal degrada-
tion of metalloproteins. The hydroxyl radicals formed then
cause rupture of the lysosomes. This allows some of the
redox-active iron to reach the nucleus and react with H2O2
to form hydroxyl radicals that damage DNA. Consequently,
cell cycle arrest and/or apoptosis occur. All of these events
induced by H2O2 can be prevented by DFO, which has been
attributed to the capacity of DFO to chelate redox-active
iron in the lysosomal but also endosomal compartments of
the cell [19,30,31].
The function of the GADD153 gene product is not
completely known. However, GADD153 protein belongs
to the CCAAT/enhancer binding protein (C/EBP) family of
transcription factors [32]. There is evidence that GADD153
is directly involved in triggering apoptosis, based primarily
on the finding that targeted overexpression of a GADD153
vector in several different cell lines resulted in apoptosis
[33]. Furthermore, several recent studies [26,34–36] have
suggested that the increased GADD153 gene expression
caused by various inducers of apoptosis somehow triggers
the critical early events leading to the initiation of apoptosis.
Therefore, because there is substantial evidence to support
the concept that GADD153 has a role in triggering apopto-
sis, it is conceivable that the increased GADD153 protein
expression in iron-deficient Jurkat T-lymphocytes could be
involved in triggering apoptosis in these cells. This is not to
say, however, that other apoptosis-related genes or gene
products are unimportant in the apoptosis induced by DFO.
In particular, one study has suggested a potential role for the
Bcl-2 gene family, based on the finding that DFO induced
apoptosis in MCF-7 human breast cancer cells, in associa-
tion with changes in the expression of the pro-apoptotic Bax
gene and the anti-apoptotic Bcl-2 gene [9]. Thus, besides
GADD153 gene expression being changed, it is possiblethat Bax and Bcl-2 gene expression was changed as well in
DFO-treated Jurkat T-lymphocytes in helping to trigger
apoptosis.
In conclusion, DFO-induced iron deficiency in Jurkat T-
lymphocytes caused caspase-3-dependent programmed cell
death, in association with increased GADD153 mRNA
expression that was due to increased transcription rather
than increased stability. The effect of cellular iron deficiency
on GADD153 mRNA did not seem to involve reactive
oxygen species, and, accordingly, was not a consequence
of oxidative DNA damage. Because GADD153 protein was
expressed as a result of treating the cells with DFO, a
possible role for GADD153 in triggering DFO-induced
apoptosis is under investigation.Acknowledgements
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